EMC was part of the international H2020 project "RELENT"
Our latest publications:
H.-G. Rammensee, K.-H. Wiesmüller, P. A. Chandran et al. (2019) A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer. J. immunotherapy cancer 7, 307 doi:10.1186/s40425-019-0796-5.
H.-G. Rammensee, C. Gouttefangeas, C. Heidu et al. (2021) Designing a SARS-CoV-2 T-cell-Inducing vaccine for high-risk patient groups. Vaccines 9, 428. https://doi.org/10.3390/vaccines9050428.
Download our lists of selected publications in the field of: